Peri-ischemic aminoguanidine fails to ameliorate neurologic and histopathologic outcome after transient spinal cord ischemia

Journal of Neurosurgical Anesthesiology

Volumn 14, Issue 1, 2002, Pages 35-42

  Lips, J ^a   De Jager, S W ^a   De Haan, P ^a   Bakker, O ^a   Vanicky, I ^a   Jacobs, M J ^a   Kalkman, C J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Balloon occlusion; Infarction volume; iNOS; Rabbit

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CELL DAMAGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; HISTOPATHOLOGY; LUMBOSACRAL SPINE; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; PARAPLEGIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN DETERMINATION; RABBIT; RECTUM TEMPERATURE; REPERFUSION; SPINAL CORD ISCHEMIA;

ANIMALS; ANTERIOR HORN CELLS; BLOOD GLUCOSE; BLOOD PRESSURE; BLOTTING, WESTERN; CARBON DIOXIDE; ENZYME INHIBITORS; GUANIDINES; HEART RATE; HEMATOCRIT; HINDLIMB; INFARCTION; LUMBOSACRAL REGION; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXYGEN; PARAPLEGIA; RABBITS; SPINAL CORD; SPINAL CORD ISCHEMIA;

EID: 0036136436     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-200201000-00007     Document Type: Article

References (23)

1. Cerebroprotective effects of aminoguanidine in a rodent model of stroke
2. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage
3. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats
4. Aminoguanidine selectively inhibits inducible nitric oxide synthase
5. Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage
6. Nitric oxide synthase in models of focal ischemia
7. Aminoguanidine attenuates focal cerebral ischemia
8. Inhibition of serum diamine oxidase discloses a constitutive putrescine release from cultured vascular smooth muscle cells
9. Cerebral ischemia enhances polyamine oxidation: Identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death
10. Effect of mild hypothermia and the 21-aminosteroid U-74389G on neurologic and histopathologic outcome after transient spinal cord ischemia in the rabbit
11. Neuroprotective effects of riluzole and ketamine during transient spinal cord ischemia in the rabbit
12. The efficiency of systematic sampling in stereology and its prediction
13. ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia
14. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein
15. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene
16. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia
17. Polyamine metabolism in reversible cerebral ischemia
18. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines
19. Polyamine oxidase, properties and functions
20. Effects of MDL 72527, a specific inhibitor of polyamine oxidase, on brain edema, ischemic injury volume, and tissue polyamine levels in rats after temporary middle cerebral artery occlusion
21. The neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats
22. Neuropathology of experimental spinal cord ischemia in the rabbit